Valmark Advisers’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-123,203
Closed -$336K 646
2025
Q1
$336K Buy
123,203
+7,549
+7% +$29.8K 0.01% 492
2024
Q4
$481K Buy
115,654
+2,478
+2% +$9.37K 0.01% 425
2024
Q3
$440K Sell
113,176
-342
-0.3% -$1.44K 0.01% 440
2024
Q2
$445K Sell
113,518
-2,562
-2% -$11K 0.01% 414
2024
Q1
$486K Buy
116,080
+32,153
+38% +$151K 0.01% 386
2023
Q4
$394K Buy
+83,927
New +$327K 0.01% 389
2023
Q3
Sell
-163,056
Closed -$748K 481
2023
Q2
$748K Buy
163,056
+91,177
+127% +$419K 0.02% 267
2023
Q1
$356K Buy
71,879
+30,202
+72% +$149K 0.01% 365
2022
Q4
$228K Buy
41,677
+7,118
+21% +$43.6K 0.01% 408
2022
Q3
$225K Buy
+34,559
New +$193K ﹤0.01% 383

Other funds holding MXCT